Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain

Pharmacy World and Science

Volumn 31, Issue 3, 2009, Pages 406-412

  R Martínez Pérez, Sebastián ^a   D Armando, Pedro ^b   C Molina Guerra, Andrea ^a   Martí Pallarés, Mercé ^c   Martínez Martínez, Fernando ^d  

^a Farmacia Ldo Sebastián R Martínez Pérez ^*  (Spain)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c Pharmaceutical Care Foundation of Spain   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Age; Community pharmacy; Diabetes; Gender; Hypertension; Obesity; Prevalence; Risk factor; Spain

Indexed keywords

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; COMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PHARMACIST; PREVALENCE; SMOKING; SPAIN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PHARMACISTS; RISK FACTORS; SEX FACTORS; SPAIN; YOUNG ADULT;

EID: 67349120265     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-008-9267-7     Document Type: Article

References (40)

1. M Moser 1996 Management of hypertension, part I Am Fam Physician 53 7 2295 302 (Pubitemid 26163272)
2. Guidelines Committee 2007 Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 1105 87 10.1097/HJH.0b013e3281fc975a (Pubitemid 46924065)
3. Guidelines Committee 2003 European society of hypertension - European society of cardiology guidelines for the management of arterial hypertension J Hypertens 21 6 1011 53 10.1097/00004872-200306000-00001 (Pubitemid 36667855)
4. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. doi: 10.1001/jama.289.19.2560 .
5. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Six Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 6 report. Arch Intern Med. 1997;157:2413-46. doi: 10.1001/archinte.157.21. 2413 .
6. Guidelines Sub-Committee 2003 World Health Organization (WHO)/International society of hypertension (ISH) statement on management of hypertension J Hypertens 21 11 1983 92 10.1097/00004872-200311000-00002 (Pubitemid 38296854)
7. Williams B, et al. Guidelines for management of hypertension: report of the fourth working party of the British hypertension society, 2004 - BHS IV. J Human Hypertens. 2004; 18(3): 139-85.
8. R Marín A de la Sierra P Armario C Campo JR Banegas M Gorostidi 2005 Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005 Med Clin (Barc) 125 1 36 46 10.1157/13076404 Guidelines on the diagnosis and treatment of arterial hypertension in Spain 2005
9. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur Heart J. 2003; 24: 1601-10.
10. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004; 328: 634-40.
11. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003; 108: 2154-69.
12. American Diabetes Association 2004 Position statement. Hypertension management in adults with diabetes Diabetes Care 27 Suppl 1 65 67 10.2337/diacare.27.2007.S65
13. X Gired JJ Mourad B Vaïsse P Poncelet JM Mallion D Herpin 2003 Estimation du nombre des sujets traités pour une HTA, una diabète ou une hyperlipidémie en France: étude FLASH 2002 Arch Mal Coeur 96 750 3 Estimation of the number of subjects treated for ATH, diabetes, or hyperlipidemia in France: FLAHS study 2002 (Pubitemid 36966328)
14. JR Banegas F Rodríguez-Artalejo LM Ruilope A Graciani M Luque JJ de la Cruz-Troca 2002 Hypertension magnitude and management in the elderly population of Spain J Hypertens 20 2157 64 (Pubitemid 35388233)
15. JR Banegas J Segura LM Ruilope M Luque R García-Robles C Campo 2004 Blood pressure control and physician management of hypertension in hospital hypertension units in Spain Hypertension 43 1338 44 10.1161/01.HYP.0000127424. 59774.84 (Pubitemid 38691759)
16. JR Banegas F Rodríguez Artalejo 2002 El problema de la hipertensión arterial en España Rev Clin Esp 202 12 5 The problem of hypertension in Spain
17. De la Figuera M, Arnau JM, Brotons C. Hipertensión arterial en Atención Primaria. [Arterial hypertension in primary care]. Badalona: Euromedice; 2002. ISBN 84-931353-0-5.
18. PK Whelton 1994 Hypertension epidemiology Lancet 344 101 6 10.1016/S0140-6736(94)91285-8 (Pubitemid 24214139)
19. DM Lloyd-Jones MG Larson EP Leip A Beiser RB D Agostino WB Kannel 2002 Lifetime risk for developing congestive heart failure The Framingham heart study Circulation 106 1 5 (Pubitemid 35440290)
20. Mataix J, García torres L. Hipertensión arterial. [Arterial hypertension]. En: Mataix J. Nutrición y alimentación humana. [Nutricion and human alimentation]. Madrid: Ergon; 2002. ISBN 84-8473-088-3.
21. J Mayo Nápoles R Pila Pérez P Hernández Mandado R Pila Peláez C Guerra Rodríguez 2000 Hipertensión arterial en el joven: factores de riesgo Rev Med Uruguay 16 24 30 Arterial hypertension in the young: risk factors
22. AJ Zillich JM Sutherland PA Kumbera BL Carter 2005 Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study) J Gen Intern Med 20 1091 96 10.1111/j.1525-1497.2005.0226.x (Pubitemid 43110257)
23. M Machado J Bajcar GC Guzzo TR Einarson 2007 Sensitivity of patient outcomes to pharmacist interventions part II: systematic review and meta-analysis in hypertension management Ann Pharmacother 41 11 1770 81 10.1345/aph.1K311 (Pubitemid 350044338)
24. AC Oparah DU Adje EF Enato 2006 Outcomes of pharmaceutical care intervention to hypertensive patients in a Nigerian community pharmacy Int J Pharm Pract 14 2 115 22 10.1211/ijpp.14.2.0005 (Pubitemid 43799504)
25. JD Mason CA Colley 1993 Effectiveness of an ambulatory care clinical pharmacist: a controlled trial Ann Pharmacother 27 555 8
26. NH Lobas PW Lepinski PW Abramowitz 1992 Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic Am J Hosp Pharm 49 1681 8
27. Expert Panel on the Identification. Evaluation, and treatment of overweight and obesity in adults. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults; Executive summary. Am J Clin Nutr. 1998;68:899-917.
28. Consenso SEEDO'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Sociedad Española para el Estudio de la Obesidad (SEEDO). Med Clin (Barc). 2000;115:587-97. Consensus SEEDO'2000 for the evaluation of overweight and obese people, and the establishment of therapeutic intervention. Spanish Society for the Study of Obesity (SEEDO).
29. FA McAlister SE Straus 2001 Evidence based treatment of hypertension: measurement of blood pressure an evidence based review BMJ 322 908 11 10.1136/bmj.322.7291.908 (Pubitemid 32324318)
30. E O'Brien B Waeber G Parati J Staessen MG Myers 2001 Blood pressure measuring devices: recommendations of the European Society of Hypertension BMJ 322 531 6 10.1136/bmj.322.7285.531 (Pubitemid 32230920)
31. SR Martínez Pérez FJ Sánchez Alonso MI Baena Parejo 2004 Efectos de la intervención farmacéutica en pacientes con presión arterial elevada sin tratamiento farmacológico Seguim Farmacoter 2 3 181 8 Effects of pharmaceutical intervention in patients with high blood pressure without pharmacological treatment
32. L Carrión Valero JA Carballo Herencia JA Divisón Garrote J Massó Orozco LM Artigao Rodenas C Sanchís Domenech 2002 La oficina de farmacia puede mejorar el grado de conocimiento de la hipertensión arterial Hipertension 19 7 299 304 Community pharmacies could improve awareness on arterial hypertension
33. MO Velázquez EA Lara MMY Martínez FF Márquez 2000 La detección integrada como un instrumento para vincular la prevención primaria, el tratamiento temprano y la vigilancia epidemiológica en diabetes e hipertensión arterial Rev Endocrinol Nutr 8 4 129 35 Detection integrated as an instrument linked to primary care, early treatment and epidemiological vigilance in diabetes and arterial hypertension
34. SR Martínez Pérez FJ Sánchez Alonso 2006 Determinación de factores de riesgo en pacientes con diferentes valores de presión arterial Pharm Care Esp 8 5 200 8 Determination of risk factors en patients with different values of arterial pressure
35. WO Erthun EO Agbani EE Bolaji 2005 Positive benefits of a pharmacist-managed hypertension clinic in Nigeria Public Health 119 9 792 8 10.1016/j.puhe.2004.11.009 (Pubitemid 41015440)
36. F Hourihan I Krass T Chen 2003 Rural community pharmacy: a feasible site for a health promotion and screening service for cardiovascular risk factors Aust J Rural Health 11 1 28 35 10.1046/j.1440-1584.2003.00468.x (Pubitemid 37038451)
37. BL Carter WJ Elliot 2000 Role of pharmacist in the detection, management, and control of hypertension: national call to action Pharmacotherapy 20 2 119 22 10.1592/phco.20.3.119.34778 (Pubitemid 30073831)
38. JE Borenstein G Graber E Saltiel J Wallace S Ryu J Archi 2003 Physician-pharmacist comanagement of hypertension: a randomized, comparative trial Pharmacotherapy 23 2 209 16 10.1592/phco.23.2.209.32096 (Pubitemid 36204018)
39. AJ Zillich JL Milchak BL Carter WR Doucette 2006 Utility of a questionnaire to measure physician-pharmacist collaborative relationships J Am Pharm Assoc 46 4 453 8 10.1331/154434506778073592 (Pubitemid 46037348)
40. JJ Park P Nelly BL Carter PP Burgess 1996 Comprehensive pharmaceutical care in the chain setting: drug therapy monitoring and counselling by pharmacists contributed to improved blood pressure control in study patients J Am Pharm Assoc 36 443 51